@FierceMedDev: Special Report: Top 10 Med Tech Investments of Q2. Feature | Follow @FierceMedDev
@MarkHFierce: U.K. researchers believe that low levels of a specific protein can signify aggressive colorectal cancer. More | Follow @MarkHFierce
@DamianFierce: Fresh deals and booming sales have Illumina brightening its 2013 guidance. News | Follow @DamianFierce
> Johnson & Johnson's ($JNJ) Codman unit has issued a safety warning on its MedStream infusion pump, and the FDA has assigned its most serious label to the problem. Note
> Qiagen ($QGEN) and Exosome Diagnostics have teamed up to develop and sell sample preparation kits for nucleic acid analysis. News
> Tokyo Institute of Technology scientists have developed a surgical robot they say would cost between a third and a 10th of Intuitive Surgical's ($ISRG) da Vinci system, but their prototype is at least 5 years away from clinical use. Article
> Cancer Genetics ($CGIX) has launched a new cervical cancer test, designed to screen women with HPV-positive abnormal cervical lesions. More
> Co-Diagnostics and DNA Logix have formed a joint venture to develop infectious disease tests for the developing world. Story
> Life Technologies ($LIFE) has expanded its diagnostics platform offerings, launching two new PCR systems. Item
> Hologic ($HOLX) won FDA approval to pair its Aptima HPV assay with the fully automated Panther diagnostic system. Release
Biotech News
@FierceBiotech: PR: Verastem receives orphan drug designation from the FDA for defactinib in mesothelioma. Release | Follow @FierceBiotech
@RyanMFierce: Roche highlights more upbeat PhIII data for 'breakthrough' leukemia contender. News | Follow @RyanMFierce
@EmilyMFierce: Scientists advocate for more responsible preclinical studies. Item | Follow @EmilyMFierce
> Merck advances cardio drug under FDA review. More
> Big Pharma agrees to widen access to clinical trial data. Story
> After FDA meeting, Sarepta plans fast filing for DMD drug eteplirsen. Report
Pharma News
@FiercePharma: Lilly sales up 6%, to $5.93B; Cymbalta up 22% (!). Too bad it gets generic rivals later this year. Release | Follow @FiercePharma
@CarlyHFierce: ICYMI yesterday: Special report on the projected top 20 orphan drugs of 2018... see who made the list. Feature | Follow @CarlyHFierce
> GlaxoSmithKline sales tick up, but China probe will hit growth. Story
> GlaxoSmithKline CEO says HQ, British execs 'knew nothing' of China fraud. Report
Biomarkers News
> Epigenetic tags point to a new generation of age-related biomarkers. Report
> Nerves could predict aggressiveness of prostate cancer. More
> Takeda and Zinfandel advance Alzheimer's biomarker work. Story
> Plaque buildup trajectory may serve as a clue for Alzheimer's. Article
> Autism clues: UC Davis team spots two new potential biomarkers of the condition. Item
Drug Delivery News
@MichaelGFierce: Regulus completes $49M public offering to support microRNA tech. Report | Follow @MichaelGFierce
> Novaliq secures CE mark for OTC drop to treat dry eye. News
> Supercomputer-designed hypertension drug mimics natural hormone response. Story
> Imprimis to begin osteoarthritis cream PhIII, snags transdermal wound treatment. More
> Cancer drug breaches blood-brain barrier using nanovesicles. Article
> Flowonix reports longest service life ever in 6-year Prometra trial. Item